| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87891f33f02b49f4e528ca24cb622312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98f5bc87320d5e6f71d64b6894c4df87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f4d75c63c7dca37cbf4026f2bad4090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9f2a04e8cd0083d92a8baf6545f434e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2013-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c28d99e04d238ae7192f1233c14a182b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12fea7993fdd23eca752462edc09cbed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d7647a376e9841d4746d62613d6334 |
| publicationDate |
2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2806867-A1 |
| titleOfInvention |
Method of treating tourette's disorder with gaba-aminotransferase inactivators |
| abstract |
The present invention is a method of treating Tourette's Disorder (TD) using GABA ergic drugs that elevate the amount of stored presynaptic GABA and do not significantly increase GABA tone (a continuous background level of GABA signaling) in the brain. The administration of vigabatrin and/or (1 S ,3 S )-3-amino-4-difluoromethylenyl-l-cyclopentanoic acid hydrochloride salt is expressly contemplated. |
| priorityDate |
2012-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |